Try 12 Weeks of Cell-Based Assay News for only $95!*
In today’s competitive research environment, success depends on having the most up-to-date information. Scientists and business leaders working in pre-clinical drug discovery rely on Cell-Based Assay News to bring them exclusive, in-depth business, technology, and research news on:
High-content screening
Cell-based assays
Cellular imaging
Functional genomics
In addition, every online subscription to Cell-Based Assay News provides this important coverage:
Updates on patents, licensing, and IP litigation
Technology transfer and translational research
Funding reports, including research grants and venture capital
Exclusive interviews with business, technology, and research leaders
New product launches and upgrades
Summaries of relevant research papers
Management news: hirings, firings, and promotions
Every subscriber receives a weekly email bulletin containing clickable links to the latest headlines plus unlimited full-text access to the entire online archive of Cell-Based Assay News.
*12-week introductory offer for new subscribers only. Customers who have previously ordered an introductory subscription within the past 12 months will be invoiced the difference of the full-year rate of $985.
![Publishing Systems Powered by iProduction [ralph]](/images-genomeweb/small_iproduction_logo.gif "Publishing Systems Powered by iProduction [ ralph]"){kind=logo}